Raffaella Giavazzi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Impairment of oxidative metabolism compromises Rad51 recruitment and potentiates PARP inhibitor effectiveness in ovarian cancer.

Impairment of oxidative metabolism compromises Rad51 recruitment and potentiates PARP inhibitor effectiveness in ovarian cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 23, 2025

Melanoma extracellular vesicles membrane coated nanoparticles as targeted delivery carriers for tumor and lungs.

Melanoma extracellular vesicles membrane coated nanoparticles as targeted delivery carriers for tumor and lungs.

Journal: Materials today. Bio

Published: October 21, 2024

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models.

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models.

Journal: Molecular oncology

Published: July 23, 2024

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator.

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 01, 2024

Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.

Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.

Journal: Cell death & disease

Published: April 09, 2024

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.

Journal: Frontiers in pharmacology

Published: February 22, 2024

Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.

Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.

Journal: Oncoimmunology

Published: August 04, 2023

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 22, 2023

Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.

Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.

Journal: British journal of cancer

Published: February 16, 2023

The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.

The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.

Journal: Cancer research communications

Published: October 25, 2022

Pseudo-resistance to anticancer drugs.

Pseudo-resistance to anticancer drugs.

Journal: Therapeutic advances in medical oncology

Published: July 29, 2022

Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience.

Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience.

Journal: British journal of pharmacology

Published: January 17, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026